Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
STTK
STTK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
STTK News
Shattuck Labs Reports Strong Earnings, Shares Surge 53%
4d ago
Fool
Shattuck Labs Reports Q4 and 2025 Business Update
4d ago
NASDAQ.COM
Shattuck Labs Reports 2025 Financial Results and Pipeline Progress
6d ago
NASDAQ.COM
Shattuck Labs Q4 Earnings Beat Expectations
6d ago
seekingalpha
Shattuck Labs Reports Reduced Losses in Q4
6d ago
NASDAQ.COM
Shattuck Labs Reports Progress on SL-325 Clinical Trials
6d ago
Newsfilter
Shattuck Labs to Participate in Immunology Symposium
Feb 06 2026
Newsfilter
Shattuck Labs Shares Rise After Piper Sandler Initiates Overweight Rating
Jan 28 2026
seekingalpha
Latest Rating Changes on Wall Street
Jan 28 2026
CNBC
Shattuck Labs (STTK) Stock Soars 74% Following Analyst Upgrade to Buy
Jan 06 2026
Fool
Shattuck Labs Upgraded to Buy by Analyst, Stock Surges 74%
Jan 06 2026
NASDAQ.COM
Shattuck Labs Upgraded to Buy by Analyst, Stock Soars 74%
Jan 06 2026
Yahoo Finance
Shattuck Labs Grants 206,000 Stock Options to Attract New Executive
Dec 15 2025
Globenewswire
Shattuck Labs (STTK) Price Target Raised by 33.33% to $4.08
Dec 06 2025
NASDAQ.COM
Analyst Upgrade Enhances Confidence in Shattuck's Next-Gen Inflammatory Bowel Disease Treatment
Dec 01 2025
Benzinga
Shattuck Labs to Attend Investor Conferences Scheduled for December
Nov 20 2025
Newsfilter
Show More News
